Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2005-07-14
2008-11-04
Parkin, Jeffrey S. (Department: 1648)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Reexamination Certificate
active
07446170
ABSTRACT:
A polypeptide represented by SEQ. ID No. 13, a polypeptide represented by SEQ. ID No. 30 or functional equivalents thereof and a polypeptide represented by SEQ. ID No. 17.
REFERENCES:
patent: 4994559 (1991-02-01), Moscatelli et al.
patent: 5026839 (1991-06-01), Moscatelli et al.
patent: 5302701 (1994-04-01), Hashi et al.
patent: 5399346 (1995-03-01), Anderson et al.
patent: 5492890 (1996-02-01), Ginsberg et al.
patent: 0 207 751 (1987-01-01), None
patent: 62-89699 (1987-04-01), None
patent: 63-501953 (1988-08-01), None
patent: 7-504812 (1995-06-01), None
patent: 10029952 (1998-02-01), None
patent: WO 92/17210 (1992-10-01), None
patent: WO 93/09221 (1993-05-01), None
patent: WO 94/10323 (1994-05-01), None
patent: WO 95/26200 (1995-10-01), None
Barkalow, F. J., et al., 1991, “Localization of the major heparin-binding site in fibronectin”, J. Biol. Chem. 266(12):7812-7818.
Giovanni Paolella et al., “Sequence analysis and in vivo expression show that alternative splicing of ED-B and ED-A regions of the human fibronectin gene are independent events”, Nucleic Acids Research, vol. 16, No. 8, 1988, pp. 3545-3557.
Bing Lim et al., “Long-term expression of human adenosine deaminase in mice transplanted with retrovirus-infected hematopoietic stem cells”, Proc. Natl. Acad. Sci. USA, vol. 86, Nov. 1989, pp. 8892-8896.
Michael H. Ross, Ph.D. et al.,Histology: A Text and Atlas, Williams & Wilkins, Baltimore, 1989, pp. 192-195.
Hiroshi Neda et al., “Chemical Modification of an Ecotropic Murine Leukemia Virus Results in Redirection of Its Target Cell Specificity”, The Journal of Biological Chemistry, vol. 266, No. 22, Aug. 5, 1991, pp. 14143-14146.
Thomas M. Devlin, Ph.D.,Textbook of Biochemistry With Clinical Corrections, Wiley-Liss, New York, 1992, pp. 1151-1154.
Gay M. Crooks et al., “Growth Factors Increase Amphotropic Retrovirus Binding to Human CD34+Bone Marrow Progenitor Cells”, Blood, vol. 82, No. 11, Dec. 1, 1993, pp. 3290-3297.
Hugo Soudeyns et al., “Identification of a Novel Glucocorticoid response Element within the Genome of the Human Immunodeficiency Virus Type 1”, Virology, vol. 194, pp. 758-768.
Mariann Grossman et al., “Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia”, Nature Genetics, vol. 6, Apr. 1994, pp. 335-341.
Thomas Moritz et al., “Bone Marrow Extracellular Matrix Molecules Improve Gene Transfer into Human Hematopoietic Cells via Retroviral Vectors”, J. Clin. Invest., vol. 93, Apr. 1994, pp. 1451-1457.
E.G. Nabel et al., “Recombinant growth factor gene expression in vascular cells in vivo”, Annals of the New York Academy of Sciences, Apr. 18, 1994, 714:247-52.
Noriyuki Kasahara et al., “Tissue-Specific Targeting of Retroviral Vectors Through Ligand-Receptor Interactions”, Science, vol. 266, Nov. 25, 1994, pp. 1373-1376.
E.L.W. Kittler et al., “Enhancement of Retroviral Integration by Cytokine Stimulation Impairs Engraftment of Bone Marrow Cells into Non-Myeloablated Hosts”, Blood, vol. 84 (10 Suppl. 1), 1994, pp. 344a (col. 1360).
Thomas Moritz, MD et al., “Gene transfer into the hematopoietic system”, Current Science/Current Opinion in Hematology, 1994, pp. 423-428.
Akio Ido et al., “Gene Therapy for Hepatoma Cells Using a Retrovirus Vector Carrying Herpes Simplex Virus Thymidine Kinase Gene under the Control of Human α-Fetoprotein Gene Promoter”, Cancer Research 55, Jul. 15, 1995, pp. 3105-3109.
Thierry Vandendriessche et al., “Inhibition of Clinical Human Immunodeficiency Virus (HIV) Type I Isolates in Primary CD4+T Lymphocytes by Retroviral Vectors Expressing Anti-HIV Genes”, Journal of Virology, vol. 69, No. 7, Jul. 1995, pp. 4045-4052.
Robin A. Weiss et al., “Retrovirus Receptors”, Cell, vol. 82, Aug. 25, 1995, pp. 531-533.
Claudio Bordignon et al., “Gene Therapy in Peripheral Blood Lymphocytes and Bone Marrow for ADA-Immunodeficient Patients”, Science, vol. 270, Oct. 20, 1995, pp. 470-474.
Donald B. Kohn, MD, “The current status of gene therapy using hematopoietic stem cells”, Current Science/Current Opinion in Pediatrics, 1995, pp. 56-63.
Peter J. Quesenberry, “Hemopoietic stem cells, progenitor cells, and cytokines”,Williams Hematology, Fifth Edition, McGraw-Hill, Inc., New York, 1995, pp. 211-215.
Christopher E. Walsh et al., “Gene therapy”,Williams Hematology, Fifth Edition, McGraw-Hill, Inc., New York, 1995, pp. 195-199.
Helmut Hanenberg et al., “Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells”, Nature Medicine, vol. 2, No. 8, Aug. 1996, pp. 876-882.
Thomas Moritz et al., “Fibronectin Improves Transduction of Reconstituting Hematopoietic Stem Cells by Retroviral Vectors: Evidence of Direct Viral Binding to Chymotryptic Carboxy-Terminal Fragments”, Blood, vol. 88, No. 3, Aug. 1, 1996, pp. 855-862.
Thomas J. Wickham et al., “Targeted Adenovirus Gene Transfer to Endothelial and Smooth Muscle Cells by Using Bispecific Antibodies”, Journal of Virology, vol. 70, No. 10, Oct. 1996, pp. 6831-6838.
John M. Coffin, “Retroviridae: The Viruses and Their Replication”,Fields Virology, Third Edition, Lippincott-Raven Publishers, Philadelphia, 1996, pp. 1769-1771 and 1787-1791.
David M. Knipe, “Virus-Host Cell Interactions”,Fields Virology, Third Edition, Lippincott-Raven Publishers, Philadelphia, 1996, pp. 275-279.
Valérie Dardalhon et al., “Green Fluorescent Protein as a Selectable Marker of Fibronectin-Facilitated Retroviral Gene Transfer in Primary Human T Lymphocytes”, Human Gene Therapy, Jan. 1, 1999, pp. 5-14.
Scott S. Case et al., “Stable transduction of quiescent CD34+CD38−human hematopoietic cells by HIV-1-based lentiviral vectors”, Proc. Natl., Acad. Sci. USA, vol. 96, Mar. 1999, pp. 2988-2993.
Vivienne I. Rebel et al., “One-Day Ex Vivo Culture Allows Effective Gene Transfer Into Human Nonobese Diabetic/Severe Combined Immune-Deficient Repopulating Cells Using High-Titer Vesicular Stomatitis Virus G Protein Pseudotyped Retrovirus”, Blood, vol. 93, No. 7, Apr. 1, 1999, pp. 2217-2224.
Asada Kiyozo
Hashino Kimikazu
Kato Ikunoshin
Koyama Nobuto
Uemori Takashi
DLA Piper (LLP) US
Parkin Jeffrey S.
Takara Bio Inc.
LandOfFree
Method for gene transfer into target cells with retrovirus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for gene transfer into target cells with retrovirus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for gene transfer into target cells with retrovirus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4051475